Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma
Clinical trial NCT00556049 · COMPLETED
Trial details
- NCT number
- NCT00556049
- Sponsor
- Massachusetts General Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-12-01
- Primary completion
- 2013-12-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.